A new medical study published this month suggests yes — with some key factors to keep in mind. Ozempic’s long-term impact.

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

So having all this in mind, we designed this study to look at longer-term weight outcomes in patients with obesity who received injectable semaglutide or liraglutide, either for obesity or type 2 ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...